Medicare Enrolled
Dr. Vivian Cline, MD
Hematology & Oncology · Round Rock, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cline from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cline? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cline
Dr. Vivian Cline is a hematology & oncology in Round Rock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Cline performed 61,174 Medicare services across 3,010 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cline received a total of $8,923 from 70 pharmaceutical and/or device companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cline is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 15% volume in TX$ $8,923 industry payments
Medicare Practice Summary
Medicare Utilization ↗61,174
Medicare services
Top 15% in TX for hematology & oncology
3,010
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,220 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 19,000 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 13,800 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 11,000 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 5,340 | $19 | $66 |
| Immune globulin infusion (Octagam) | 2,130 | $33 | $233 |
| Dexamethasone injection (steroid) | 1,172 | $0 | $1 |
| Injection, fulvestrant, 25 mg | 1,000 | $8 | $244 |
| Blood draw (venipuncture) | 968 | $8 | $20 |
| Complete blood count (CBC) with differential | 871 | $8 | $36 |
| Injection, granisetron hydrochloride, 100 mcg | 740 | $0 | $24 |
| Comprehensive metabolic blood panel | 398 | $10 | $64 |
| Office visit, established patient (30-39 min) | 384 | $93 | $368 |
| Office visit, established patient (20-29 min) | 371 | $63 | $250 |
| Injection, zoledronic acid, 1 mg | 300 | $6 | $431 |
| Administration of chemotherapy into vein, 1 hour or less | 290 | $102 | $707 |
| Carcinoembryonic antigen (cea) protein level | 223 | $18 | $99 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 216 | $23 | $157 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 212 | $49 | $313 |
| Drug injection, under skin or into muscle | 180 | $11 | $96 |
| Immunoglobulin level test | 123 | $9 | $56 |
| Injection of additional new drug or substance into vein | 121 | $12 | $108 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 114 | $20 | $128 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 111 | $25 | $145 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 108 | $16 | $100 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 106 | $58 | $211 |
| Infusion, normal saline solution , 1000 cc | 101 | $2 | $19 |
| Microscopic examination for white blood cells with manual cell count | 98 | $4 | $22 |
| Complete blood count (CBC), automated | 98 | $6 | $34 |
| Measurement of immunoglobulin light chains | 90 | $17 | $60 |
| Vitamin D level test | 88 | $29 | $250 |
| Lactate dehydrogenase (enzyme) level | 83 | $6 | $31 |
| Administration of chemotherapy into vein, each additional hour | 82 | $22 | $161 |
| Ferritin level test (iron stores) | 79 | $13 | $60 |
| Iron level test | 77 | $6 | $27 |
| Iron binding capacity test | 77 | $8 | $35 |
| Injection, diphenhydramine hcl, up to 50 mg | 77 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) | 76 | $131 | $496 |
| Thyroid stimulating hormone (TSH) test | 74 | $16 | $80 |
| Infusion into a vein for hydration, each additional hour | 63 | $10 | $75 |
| Vitamin B-12 level test | 46 | $15 | $76 |
| Red blood count, automated test | 45 | $4 | $23 |
| Infusion into a vein for hydration, 31-60 minutes | 45 | $26 | $256 |
| Administration of additional new drug or substance into vein, 1 hour or less | 40 | $51 | $344 |
| Protein measurement, serum | 39 | $11 | $99 |
| Immunologic analysis technique on serum | 39 | $29 | $108 |
| Immunologic analysis technique on serum (immunofixation) | 39 | $22 | $160 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 38 | $363 | $1,722 |
| Folic acid level test | 35 | $14 | $73 |
| Beta-2 microglobulin (protein) level | 31 | $16 | $96 |
| PSA test (prostate cancer screening) | 31 | $18 | $94 |
| Administration of additional new drug or substance into vein using push technique | 29 | $43 | $289 |
| Irrigation of implanted venous access drug delivery device | 29 | $18 | $114 |
| Office visit, established patient (10-19 min) | 28 | $38 | $150 |
| Hospital follow-up visit, high complexity | 28 | $94 | $357 |
| Drawing of blood for a medical problem | 26 | $59 | $264 |
| New patient office visit (45-59 min) | 25 | $125 | $565 |
| Reticulated (young) platelet measurement | 24 | $35 | $143 |
| Injection of drug or substance into vein | 24 | $28 | $247 |
| Hospital follow-up visit, moderate complexity | 24 | $62 | $247 |
| Urinalysis with microscopic exam | 22 | $3 | $28 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 18 | $90 | $657 |
| New patient office visit, complex (60-74 min) | 16 | $161 | $709 |
| Initial hospital admission, moderate complexity | 12 | $102 | $470 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.7% high complexity
87.3% medium
8.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,923
Total received (2018-2024)
Avg $1,275/year across 7 years
Top 33% in TX for hematology & oncology
70
Companies
410
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,632 (85.5%)
Other
Charitable contributions, space rental, and other categories
$1,040 (11.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$250 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,497
2023$2,113
2022$1,973
2021$543
2020$153
2019$886
2018$759
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,331
Janssen Biotech, Inc.
$998
E.R. Squibb & Sons, L.L.C.
$736
PFIZER INC.
$484
Lilly USA, LLC
$388
Seagen Inc.
$337
AstraZeneca Pharmaceuticals LP
$315
GENZYME CORPORATION
$303
Daiichi Sankyo Inc.
$301
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Incyte Corporation
$233
Amgen Inc.
$223
Astellas Pharma US Inc
$189
Regeneron Healthcare Solutions, Inc.
$174
Bayer HealthCare Pharmaceuticals Inc.
$147
Eisai Inc.
$134
Celgene Corporation
$124
Dova Pharmaceuticals
$117
Alexion Pharmaceuticals, Inc.
$97
ARRAY BIOPHARMA INC
$96
Merck Sharp & Dohme LLC
$94
Gilead Sciences, Inc.
$94
Takeda Pharmaceuticals U.S.A., Inc.
$92
GlaxoSmithKline, LLC.
$81
ADC Therapeutics America, Inc.
$79
Genentech USA, Inc.
$73
SpringWorks Therapeutics, Inc.
$72
Pharmacyclics LLC, An AbbVie Company
$66
TerSera Therapeutics LLC
$64
PharmaEssentia USA Corporation
$59
Merck Sharp & Dohme Corporation
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Kite Pharma, Inc.
$52
Blueprint Medicines Corporation
$51
Stemline Therapeutics Inc.
$47
Agios Pharmaceuticals, Inc.
$45
Adaptive Biotechnologies Corporation
$45
Apellis Pharmaceuticals, Inc.
$44
EISAI INC.
$43
Sobi, Inc
$37
G1 Therapeutics, Inc.
$35
Emmaus Medical, Inc.
$35
Karyopharm Therapeutics Inc.
$33
Puma Biotechnology, Inc.
$32
Rigel Pharmaceuticals, Inc.
$32
Pharmacosmos Therapeutics Inc.
$31
Deciphera Pharmaceuticals Inc.
$31
Acrotech Biopharma LLC
$24
SK Life Science, Inc.
$24
Mirati Therapeutics, Inc.
$24
AbbVie Inc.
$23
CSL Behring
$23
Jazz Pharmaceuticals Inc.
$23
CTI BioPharma Corp.
$23
Secura Bio, Inc.
$22
JAZZ PHARMACEUTICALS INC.
$21
Aveo Pharmaceuticals, Inc.
$20
ABBVIE INC.
$19
NESTLE HEALTHCARE NUTRITION INC.
$19
AMAG Pharmaceuticals, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Taiho Oncology, Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$17
BeiGene USA, Inc.
$16
Kyowa Kirin, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$15
SERVIER PHARMACEUTICALS LLC
$14
Seattle Genetics, Inc.
$12
Exelixis Inc.
$12
Janssen Pharmaceuticals, Inc
$6
Top 3 companies account for 34.4% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADVATE · AKYNZEO · ALIMTA · AYVAKIT · Alecensa · Aranesp · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · EMEND · ENHERTU · ERBITUX · ERLEADA · Empaveli · Endari · Enhertu · Erleada · FARYDAK · FERAHEME · FOTIVDA · Fabhalta · GILOTRIF · HEMGENIX · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Polivy · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · Stivarga · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VYXEOS · Vanflyta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · ZENPEP · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $15 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
28
Per 100K population
4.3
County median income
$108,309
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER - ROUND ROCK
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cline is a mixed practice specialist, with above-average Medicare volume (top 15% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cline experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Cline performed 19,000 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cline receive payments from pharmaceutical companies?
Yes. Dr. Cline received a total of $8,923 from 70 companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cline's costs compare to other hematology & oncologys in Round Rock?
Dr. Cline's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cline) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Round Rock
Browse hematology & oncologys in Round Rock ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology